Lee et al.’s experimental data showed that the reduction of DNA methyltransferase 1 (DNMT1) expression with 5-azacytidine treatment, a global demethylation agent, could induce EMT, and the cancer stem cell phenotype in prostate cancer cells and in turn promote cancer metastasis (20). This evidence concerns the gene DNMT1 and Familial prostate cancer.